24-Mar-2006 - Proteome Sciences plc

Proteome Systems hits second milestone in the development of a rapid diagnostic test to detect active TB

Proteome Systems announced that its international partner, the Foundation for Innovative New Diagnostics (FIND), has signed off on the second Milestone in its Tuberculosis [TB] diagnostic program. Proteome Systems has discovered and patented TB proteins in human sputum and blood that can be used to diagnose active tuberculosis. There is currently no point-of-care [POC] test to detect TB in its active form. This recent milestone involved producing and using antibodies for the detection of these unique TB proteins in clinical samples.

FIND CEO Giorgio Roscigno said that reaching this second milestone is important particularly as it coincides with World TB Day when partners worldwide are renewing their commitment to rally behind the new ten- year Global Plan to stop TB (2006-2015).

Facts, background information, dossiers
More about Proteome Sciences
  • News

    Thermo Fisher Scientific and Proteome Sciences Form Protein Biomarker Collaboration

    Thermo Fisher Scientific Inc. and Proteome Sciences plc announced the companies will collaborate to deliver products for protein biomarker research. The collaboration unites the talent and resources of the proteomics reagent team at the Thermo Fisher Scientific Biomarker Research Initiative ... more

    Millipore and Proteome Sciences Announce Licensing Agreement

    Millipore Corporation and Proteome Sciences plc announced they have signed an exclusive license agreement to develop new products that will help to advance the study of Alzheimer’s disease. Under the terms of the agreement, Millipore will develop Luminex bead-based multiplex immunoassays to ... more

  • Companies

    Proteome Sciences plc

    Proteome Sciences is a global leader in applied proteomics and uses high sensitivity proprietary technologies for protein biomarker discovery, validation and assay development. The Company’s own research has discovered a large number of novel protein biomarkers in key human diseases and is ... more

More about Foundation for Innovative New Diagnostics